The Pharmaceutical Resources Branch (PRB), Developmental Therapeutics Program (DTP), Division of Cancer Treatment and Diagnosis (DCTD), National Cancer Institute (NCI), iuses the services of this contractor to store, test and evaluate shelf life samples of investigational cancer drug formulations and report the results of such testing to the Food and Drug Administration on a periodic basis . These reports are also used for providing NCI and its investigators with information regarding the proper storage and handling of various cancer drug products under investigation, for determining appropriate expiration dates for the products, and to support NCI's Investigational New Drug Applications (INDs) filed with the Food and Drug Administration (FDA). This contract is essential for continued assurance of the quality of drugs undergoing clinical investigation for different types of cancer by Cancer Therapeutics Evaluation Program.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Resource and Support Contracts (N02)
Project #
261200700021C-5-0-1
Application #
8070793
Study Section
Project Start
2007-08-01
Project End
2012-07-31
Budget Start
Budget End
Support Year
Fiscal Year
2010
Total Cost
$550,000
Indirect Cost
Name
Midwest Research Institute
Department
Type
DUNS #
007173453
City
Kansas City
State
MO
Country
United States
Zip Code
64110